[e-drug] EP Working Group on Innovation, Acess and Poverty-related Diseases

E-DRUG" EP Working Group on Innovation, Acess and Poverty-related Diseases
--------------------------------------------------------------

Inauguration: European Parliament Working Group on Innovation, Access to Medicines and
Poverty-Related Diseases

Putting Patients' Needs First: Supporting better access and innovation for medicines for combating poverty-related diseases

INVITATION
Inauguration of the European Parliament Working Group on Innovation, Access to Medicines
and Poverty-Related Diseases
- Jan 27 Brussels

Mezzanine, 3rd floor JAN building, European Parliament, Brussels
27 January 2010 12:00-14:00
Refreshments will be provided

In a world where medical advances have produced substantial gains in life
expectancy and quality of life for so many in rich countries, still one in
three people around the world don’t have access to the medicines they need
to fight poverty-related diseases. There is an urgent need to develop and
support policies that will improve access to existing medicines and
stimulate the research and development of better medical tools for people
in poor countries suffering from poverty-related diseases. When diseases
are fought wisely and widely, we can contain drug resistance, facilitate
sustainable development, stimulate economic growth, ensure greater global
public health security, and save human lives.

The Working Group on Innovation, Access to Medicines and Poverty Related
Diseases, is being established to serve as a discussion forum with Members
of the European Parliament, the European Commission and civil society so
as to better integrate the European Union's response on health related
issues, specifically on HIV and AIDS, Tuberculosis, malaria and other
neglected diseases, as well as to ensure coherent policies on these
topics.

The Working Group has the pleasure of inviting you to its inauguration.

On this occasion, the Chair of the Working Group, the MEP David Martin,
Medecins Sans Frontieres' Access to Essential Medicines Campaign and
Global Health Advocates will give presentations setting out the aims,
activities and immediate challenges ahead for the Working Group.

For more information and to register please email Elisa Baldini at
elisa.baldini@msf.org by January 18th, 2010.
To become member of the group please contact Elisa Baldini.

Alexandra Heumber
EU & IP Policy Adviser
Medecins Sans Frontieres
Access to Essential Medicines Campaign
Rue Dupre, 94. 1090 Brussels
++32 (0) 2 474 75 09 (Dir off)
++ 32 (0) 479 514 900 (Mob)
++ 32 (0) 2 474 75 75 (Fax)
Alexandra HEUMBER <Alexandra.HEUMBER@brussels.msf.org>